Phase I clinical trials are the earliest stage of testing new cancer treatments in humans. These trials are primarily designed to assess the safety, tolerability, and appropriate dosage of new therapies, which can include drugs, biologics, or other treatments. They provide essential data that will guide further development in later trial phases.
